Jazz Pharmaceuticals plc (JAZZ) › Shareholders' EquityJazz Pharmaceuticals plc (JAZZ) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2008: -$92.88M2009: -$72.83M2010: $30.55M2011: $192.79M2012: $1.12B2013: $1.30B2014: $1.37B2015: $1.60B2016: $1.88B2017: $2.71B2018: $2.76B2019: $3.11B2020: $3.66B2021: $3.97B2022: $3.09B2023: $3.74B2024: $4.09B2025: $4.32B$4.32B2008Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$4.32B+5.5%2024$4.09B+9.5%2023$3.74B+21.1%2022$3.09B-22.2%2021$3.97B+8.3%2020$3.66B+17.6%2019$3.11B+12.8%2018$2.76B+1.6%2017$2.71B+44.5%2016$1.88B+17.4%2015$1.60B+16.6%2014$1.37B+5.8%2013$1.30B+15.5%2012$1.12B+481.6%2011$192.79M+531.0%2010$30.55M+141.9%2009-$72.83M+21.6%2008-$92.88M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share